up protherics
26 Oct 2016
Re: My advise is... Not so sure about that. They have evidently bought this on the cheap. So earnings enhancing from day one.. I would imagine that they could be a target themselves.
Ambiorix1
26 Oct 2016
Re: My advise is... Never buy the buyer...that is fundamental knowledge.Ambiorix.
up protherics
26 Oct 2016
Re: My advise is... I anticipate holding out until this is finalised. We may be able to force a trading update before this happens as this may bring the full potential of CRX to the wider market.. Personally I cannot believe that no one else is looking at this.. They must be worth at least 70 million.Also they are sitting on cash reserves of anything between six and ten millionI may even buy Evotec if this goes through at this level
Ambiorix1
26 Oct 2016
My advise is... I had a large holding in Evotec and Cypro...untill last week. I sold both a few days ago not knowing what was coming (sold Evotec at 5.09 and Cypro at 1.50 and made more than 75% on both in less than a year). Since then Evotec is down a few cents and Cypro just up 7 p. and it will probably not go up much more for some time to come. Perfect timing for me. I felt both were trading sideways and were fully valued. My advise is, sell now and make some 10% on something else before the year end. Maybe by following the money...of Oryx. They sell an fully valued Cypro to German Evotec and what have they been doing recently? Reinvesting in an undervalued German portfolio you all know... Quantum Pharma. Could be a good idea regardless the negative critics on Quantum Pharma...Ambiorix.
up protherics
26 Oct 2016
Re: Don't do anything A couple of points here.. Have you noticed there has been no trading update and inmo there wont be until the offer is finalised. Obvious why as any update will show how ridiculous this offer is.Even without growth revenues will be 10-20% higher due to Sterlings weakness. Then we have projects coming on stream together with new assays added.As you know I have been very negative as to how they raised the funds in the first. If you remember when these were first raised I said that Trident would end up with a controlling interest if they decided to convert. In effect this company was taken over when the loan notes were issued.INMO they were hoodwinked into this loan by a bunch of spivs. Advised by a brokerage firm emanating from Germany and then altermatly sold to a German company.. I wonder if they are also advisors to them as well.Personally I am going to do what you have intimated and do nothing as hopefully some other company out there will realise what a bargain this is and counter bid. This will no doubt get taken over either way as the board seems to have had enough of the company.One worry is that if the offer fails the board will be dispanded as they clearly have had enoug
Carefully Does It
26 Oct 2016
Don't do anything It might flush out another interested party.I was hoping to hold this for a few more years to see it flourish.At least it's a profit but I've always thought this could really run further.
up protherics
26 Oct 2016
shafted Wow1.60 a share 7.5% premium.. Notice how they didn't release a trading update. I for one will not be voting or selling my stock
up protherics
22 Oct 2016
Quantum Pharma Has anyone any views with regards to the RNS..I just been looking at Quantum Pharma and Oryx are connected with them. Also they have recently had a placing to reduce debt.INMO Cyprotex is in a much better state than them . So hopefully any merger takeover would ake Cyprotex the controlling force.
up protherics
09 Oct 2016
Maybe a Perfect combination After holding for nearly a decade. Maybe I was a bit insulate in my thinking when the company raised funds in such a way. INMO it is starting look like Cyprotex has a hugely talented bunch of people doing what they do best and city people doing what they do best. So maybe this is going to be even a bigger success than I could have imagined.
up protherics
05 Oct 2016
Re: Weak holders? Personally I still feel that this will be taken private. Which is probably why the strategic review is taking so long.It would be nice to have a positive trading update before this happens as I believe any premium will only amount to a 20 per cent increase in val
Carefully Does It
05 Oct 2016
Weak holders? I wonder if the delay on the strategic review is to get weak holders to sell up at this price?Where are the small sales going? Who is picking them up?
Carefully Does It
27 Sep 2016
Re: New Appt in USA I'm happier when I see increased revenue at the same headcount and similar fixed cost. They are probably tooled up with people now. Time to sweat the assets and take advantage of the weaker pound.
up protherics
27 Sep 2016
Re: New Appt in USA The appointment sounds good, but it would be nice to have some sort of update on the strategic revue together with a trading update.Also I always feel a lot happier when I see plenty of jobs advertised which has not been happening of late.
Carefully Does It
26 Sep 2016
New Appt in USA Good appointment and the RNS also gives some other info we all know anyway but re-iterated. This is not a Brexit dependent stock and the low £ is an opportunity.CRX in a good place, hope it's good for all shareholders and not just the big few."Within the industries in which we operate, the US is the largest market. It is important therefore that we leverage this potential opportunity."Strategic review outcome still to be published.
up protherics
14 Sep 2016
Comments Hasn't anyone any comments / views as to what may occur in the future. Or are we just left with a few shareholders now who already know what is happening.INMO.. the strategic review has gone on long enough.. Surely they have decided something by now
